EGFR nanovaccine in lung cancer treatment
<p>Lung cancer is known as the most common malignancy in the world in terms of incidence and death rate. GLOBOCAN data in 2018 showed that its prevalence reaches 11.6% with mortality reaching 1.7 million annually. The prevalence of lung cancer in Indonesia is also considerably high; there were...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
DiscoverSys
2019-12-01
|
| Series: | Bali Medical Journal |
| Subjects: | |
| Online Access: | https://balimedicaljournal.org/index.php/bmj/article/view/1494 |